LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Clinical trial NCT06632457 · RECRUITING

Trial details

NCT number: NCT06632457
Sponsor: Boehringer Ingelheim
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metabolic Dysfunction Associated Steatohepatitis

Start date: 2024-11-07
Primary completion: 2029-06-05
Enrollment: 1590

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.